Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | LDHB | P07195 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13775276 | 0.95 | CYP1A2 (0.33) | CYP1A2CYP2A6KDM1AKDM4EALDH1A1 | |
| SCHEMBL13775194 | 0.94 | KIF11 (0.34) | CYP1A2CYP2A6KDM1A | |
| SCHEMBL13775275 | 0.92 | KIF11 (0.35) | CYP1A2CYP2A6KDM1AGAA | |
| SCHEMBL14492751 | 0.89 | KDM1A (0.33) | KDM1ALMNA | |
| SCHEMBL13775214 | 0.87 | KDM1A (0.32) | KDM1A | |
| SCHEMBL13775183 | 0.84 | ALDH1A1 (0.33) | CYP1A2CYP2A6KDM1AKDM4EALDH1A1 | |
| SCHEMBL13775208 | 0.83 | — | — | |
| SCHEMBL2536348 | 0.81 | CYP1A2 (0.34) | CYP1A2CYP2A6ALDH1A1LMNAGAA | |
| SCHEMBL13775204 | 0.81 | KDM1A (0.31) | CYP1A2KDM1A | |
| SCHEMBL13775190 | 0.80 | LMNA (0.37) | KDM1AKDM4ELMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090189522-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDERNITSU KOSAN CO., LTD. (JP) | 2009-07-30 | — | — | US | disclosed |
| US-7524568-B2 | Aromatic amine derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7524568-B2 | Aromatic amine derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20080268283-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080268283-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-7425653-B2 | Aromatic amine derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2008-09-16 | — | — | US | disclosed |
| US-7425653-B2 | Aromatic amine derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2008-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268283-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | TYR, MAOA, AOC2 | CYP1A2 345/4885CYP2A6 2415/4885KDM1A 159/4885 |
| US-20090189522-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | TYR, MAOA, AOC2 | CYP1A2 345/4885CYP2A6 2415/4885KDM1A 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.